Resultado Líquido Alterar Data
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Celltrion KRW 331.35B 270.18B 2025-09
Cspc Pharmaceutical CNY 963.54M 106.35M 2025-09
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Kangmei Pharma CNY -3.82M 12.21M 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
MacroGenics USD -14.16M 30.98M 2025-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -37.96M 31.67M 2025-09
Ovoca Bio EUR -5.65M 3.28M 2022-06
Pfizer USD -1.65B 5.19B 2025-12
Pharma Mar EUR 59.66M 63.76M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Sartorius EUR 43.8M 11.3M 2025-09
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Takeda JPY 103.64B 115.44B 2025-12
Tilray USD -44.93M 44.61M 2025-09
Zz Pientze Pharmaceu CNY 687.04M 244.51M 2025-09